Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents

Cancer surgery remains the primary treatment option for most solid tumors and can be curative if all malignant cells are removed. Surgeons have historically relied on visual and tactile cues to maximize tumor resection, but clinical data suggest that relapse occurs partially due to incomplete cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez Vargas, Servando, Lin, Christie, Tran Cao, Hop S., Ikoma, Naruhiko, AghaAmiri, Solmaz, Ghosh, Sukhen C., Uselmann, Adam J., Azhdarinia, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279813/
https://www.ncbi.nlm.nih.gov/pubmed/34277418
http://dx.doi.org/10.3389/fonc.2021.674083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279813/
https://www.ncbi.nlm.nih.gov/pubmed/34277418
http://dx.doi.org/10.3389/fonc.2021.674083

Ejemplares similares